Literature DB >> 19913629

The biology of allogeneic hematopoietic cell resistance.

Judith A Shizuru1, Deepta Bhattacharya, Marina Cavazzana-Calvo.   

Abstract

At the most basic level, success of an allogeneic hematopoietic cell transplantation (HCT) procedure relies upon the engraftment of recipients with donor hematopoietic stem cells (HSCs) that will generate blood formation for the life of that individual. The formula to achieve durable HSC engraftment involves multiple factors including the recipient conditioning regimen, the nature of the genetic disparity between donor and recipient, and the content of the hematopoietic graft. Animal and clinical studies have shown that the biology of host resistance is complex, involving both immune and nonimmune elements. In this article, we review the factors that contribute to host resistance, describe emerging concepts on the basic biology of resistance, and discuss hematopoietic resistance as it relates specifically to patients with severe combined immunodeficiencies (SCID)- disorders that bring unique insights into the dynamics of cell replacement by allogeneic HSCs and progenitor cells. Copyright 2010. Published by Elsevier Inc.

Entities:  

Mesh:

Year:  2009        PMID: 19913629      PMCID: PMC4910691          DOI: 10.1016/j.bbmt.2009.11.005

Source DB:  PubMed          Journal:  Biol Blood Marrow Transplant        ISSN: 1083-8791            Impact factor:   5.742


  43 in total

1.  Physiological migration of hematopoietic stem and progenitor cells.

Authors:  D E Wright; A J Wagers; A P Gulati; F L Johnson; I L Weissman
Journal:  Science       Date:  2001-11-30       Impact factor: 47.728

Review 2.  Hematopoietic stem and progenitor cells: clinical and preclinical regeneration of the hematolymphoid system.

Authors:  Judith A Shizuru; Robert S Negrin; Irving L Weissman
Journal:  Annu Rev Med       Date:  2005       Impact factor: 13.739

3.  Long-term T-cell reconstitution after hematopoietic stem-cell transplantation in primary T-cell-immunodeficient patients is associated with myeloid chimerism and possibly the primary disease phenotype.

Authors:  Marina Cavazzana-Calvo; Frédérique Carlier; Françoise Le Deist; Estelle Morillon; Pierre Taupin; David Gautier; Isabelle Radford-Weiss; Sophie Caillat-Zucman; Bénédicte Neven; Stephane Blanche; Rémi Cheynier; Alain Fischer; Salima Hacein-Bey-Abina
Journal:  Blood       Date:  2007-02-01       Impact factor: 22.113

4.  CD47 is upregulated on circulating hematopoietic stem cells and leukemia cells to avoid phagocytosis.

Authors:  Siddhartha Jaiswal; Catriona H M Jamieson; Wendy W Pang; Christopher Y Park; Mark P Chao; Ravindra Majeti; David Traver; Nico van Rooijen; Irving L Weissman
Journal:  Cell       Date:  2009-07-23       Impact factor: 41.582

Review 5.  Stem-cell ecology and stem cells in motion.

Authors:  Thalia Papayannopoulou; David T Scadden
Journal:  Blood       Date:  2008-04-15       Impact factor: 22.113

6.  Enhancement of bone marrow allografts from nude mice into mismatched recipients by T cells void of graft-versus-host activity.

Authors:  T Lapidot; I Lubin; A Terenzi; Y Faktorowich; P Erlich; Y Reisner
Journal:  Proc Natl Acad Sci U S A       Date:  1990-06       Impact factor: 11.205

7.  Efficient transplantation via antibody-based clearance of hematopoietic stem cell niches.

Authors:  Agnieszka Czechowicz; Daniel Kraft; Irving L Weissman; Deepta Bhattacharya
Journal:  Science       Date:  2007-11-23       Impact factor: 47.728

Review 8.  Hematopoietic stem cell transplantation for primary immunodeficiency disease.

Authors:  C C Dvorak; M J Cowan
Journal:  Bone Marrow Transplant       Date:  2007-10-29       Impact factor: 5.483

9.  Graft rejection in recipients of T-cell-depleted HLA-nonidentical marrow transplants for leukemia. Identification of host-derived antidonor allocytotoxic T lymphocytes.

Authors:  N A Kernan; N Flomenberg; B Dupont; R J O'Reilly
Journal:  Transplantation       Date:  1987-06       Impact factor: 4.939

Review 10.  Gene therapy for severe combined immunodeficiency: are we there yet?

Authors:  Marina Cavazzana-Calvo; Alain Fischer
Journal:  J Clin Invest       Date:  2007-06       Impact factor: 14.808

View more
  6 in total

Review 1.  The road to purified hematopoietic stem cell transplants is paved with antibodies.

Authors:  Aaron C Logan; Irving L Weissman; Judith A Shizuru
Journal:  Curr Opin Immunol       Date:  2012-08-29       Impact factor: 7.486

2.  Effects of conditioning regimens and T cell depletion in hematopoietic cell transplantation for primary immune deficiency.

Authors:  Brandon M Triplett; Chong Wang; Jie Yang; Mari Dallas; Christine Hartford; Vanessa Howard; Asha Pillai; David Shook; Ashok Srinivasan; Joseph Laver; Wing Leung
Journal:  Biol Blood Marrow Transplant       Date:  2012-07-27       Impact factor: 5.742

3.  Pathways analysis of differential gene expression induced by engrafting doses of total body irradiation for allogeneic bone marrow transplantation in mice.

Authors:  Xinjian Chen; Yuanyuan Wang; Qiuxia Li; Schickwann Tsai; Alun Thomas; Judith A Shizuru; Thai M Cao
Journal:  Immunogenetics       Date:  2013-05-24       Impact factor: 2.846

4.  Fine mapping of the Bmgr5 quantitative trait locus for allogeneic bone marrow engraftment in mice.

Authors:  Yuanyuan Wang; Xinjian Chen; Schickwann Tsai; Alun Thomas; Judith A Shizuru; Thai M Cao
Journal:  Immunogenetics       Date:  2013-05-12       Impact factor: 2.846

5.  Host natural killer immunity is a key indicator of permissiveness for donor cell engraftment in patients with severe combined immunodeficiency.

Authors:  Amel Hassan; Pamela Lee; Paraskevi Maggina; Jin Hua Xu; Diana Moreira; Mary Slatter; Zohreh Nademi; Austen Worth; Stuart Adams; Alison Jones; Catherine Cale; Zoe Allwood; Kanchan Rao; Robert Chiesa; Persis Amrolia; Hubert Gaspar; E Graham Davies; Paul Veys; Andrew Gennery; Waseem Qasim
Journal:  J Allergy Clin Immunol       Date:  2014-05-01       Impact factor: 10.793

6.  Fractionated Infusion of Hematopoietic Progenitor Cells Does Not Improve Neutrophil Recovery or Survival in Allograft Recipients.

Authors:  Roni Tamari; Samantha Brown; Sean M Devlin; Satyajit Kosuri; Molly A Maloy; Doris M Ponce; Craig Sauter; Brian Shaffer; Parastoo Dahi; James W Young; Ann Jakubowski; Esperanza B Papadopoulos; Hugo Castro-Malaspina; Miguel-Angel Perales; Sergio A Giralt; Boglarka Gyurkocza
Journal:  Transplant Cell Ther       Date:  2021-06-30
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.